The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Ligand Pharmaceuticals
Approval Status: Approved June 1999
Treatment for: Infectious Diseases
General Information
Panretin (alitretinoin) Gel, 0.1%, has been approved for the treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.